1. Introduction {#sec1}
===============

In modern societies, the increasing consumer demand for natural and additive-free products has led food industry to research novel and alternative technologies in food preservation, with the objective to improve quality and safety of their products.

The use of microorganisms and/or their natural metabolites to inhibit the growth of pathogenic and spoilage bacteria has appeared as a promising tool and is also perceived by the consumer as a lower-risk food preservation \[[@B1]\]. In particular, lactic acid bacteria (LAB) have acquired considerable relevance in the food industry and in public health, since they are widely used in fermented foods, have a long history of safe use, and are commonly given the Generally Recognized As Safe (GRAS) status \[[@B2]\]. The preservative ability of LAB in food is attributed mainly to the production of antimicrobial substances, including organic acid, hydrogen peroxide, and bacteriocins \[[@B3], [@B4]\]. The latter are ribosomally synthesized, biologically active peptides or proteins with antagonistic activity against specific microorganisms \[[@B5], [@B6]\]. Many bacteriocin-producing LAB strains have proven effective against spoilage and pathogenic microorganisms in food products \[[@B7]--[@B9]\].

In the last decades, *Listeria monocytogenes* has become one of the most significant foodborne pathogens due to its widespread occurrence and its ability to tolerate environmental stresses such as low pH, low temperatures, and salt concentration up to 10% \[[@B10], [@B11]\]. These characteristics enable its frequent contamination of food products, particularly those minimally processed and refrigerated. Foodborne listeriosis is known to pose a serious health hazard when it occurs in newborns, pregnant women, and immunocompromised subjects \[[@B12], [@B13]\].

Since dairy products have been frequently reported as contaminated and associated with listeriosis outbreaks \[[@B11], [@B14]\], new preservation strategies to control growth of *L. monocytogenes* have been developed, including the direct application of bacteriocins as purified compound or the inoculation with a bacteriocin-producer LAB strain under conditions that favour production of the bacteriocin *in situ* \[[@B15]--[@B17]\]. Nisin, produced by *Lactococcus lactis,* is currently the only bacteriocin approved as preservative for utilization as direct human food ingredient \[[@B18], [@B19]\]. The *in-situ* production of a bacteriocin by potential adjuncts or starter cultures in fermentation processes requires a bacteriocinogenic strain that is well adapted to the particular food environment in which it will be used, that is able to grow under the food processing and/or storage conditions, and that produces bacteriocin in sufficient amounts to inhibit the target bacteria. LAB originally isolated from certain food products would be the best choice as starter cultures for these same products, because they would be more competitive than LAB from other sources \[[@B20]\].

With the aim of selecting LAB strains with antilisterial activity to be used as protective cultures to enhance the safety of dairy products, the antimicrobial properties of 117 *L. lactis* subsp. *lactis* isolated from artisanal Sardinian dairy products were evaluated, and six strains were found to produce bacteriocin-like substances. The capacity of these strains to antagonize *L. monocytogenes* during cocultivation in skimmed milk was also assessed. In addition, basic safety aspects of the strains such as production of biogenic amines, haemolytic activity, and antibiotic susceptibility were addressed. To our knowledge, this is the first report on the isolation of bacteriocin-like inhibitory substances from LAB strains isolated from artisanal Sardinian dairy products.

2. Materials and Methods {#sec2}
========================

2.1. Bacterial Strains and Culture Conditions {#sec2.1}
---------------------------------------------

Bacteriocin producer and indicator strains used in this study are listed in [Table 1](#tab1){ref-type="table"}. *Lactococcus lactis* subsp. *lactis* strains were identified on the basis of their morphological and biochemical characteristics as previously reported \[[@B21]\]; the identification was confirmed by PCR analysis using species-specific primers derived from 16S rRNA sequences, according to Pu et al. \[[@B22]\]. They were maintained at −20°C in M17 broth (Microbiol, Cagliari, Italy) with 15% (v/v) glycerol (Microbiol) and subcultured twice as 1% inoculums in M17 broth at 30°C for 24 h prior to experimental use. *Listeria monocytogenes* ATCC 7644, *Escherichia coli* ATCC 35150, *Enterococcus faecalis* ATCC 29212, *Staphylococcus aureus* ATCC 25923, *Lactobacillus plantarum* DSMZ 20174, and *Lactobacillus sakei*subsp. *sakei* DSMZ 20017 were used as indicators. All indicator strains were stored on nutrient broth (Microbiol) plus 20% (v/v) glycerol at −20°C except LAB strains which were maintained in MRS broth (Microbiol) with 15% (v/v) glycerol. Before use, they were subcultured twice in appropriate medium.

2.2. Screening of *Lactococcus lactis* Strains for Antimicrobial Compound Production {#sec2.2}
------------------------------------------------------------------------------------

A total of 117 *L. lactis* subsp. *lactis* strains, previously isolated from Sardinian dairy products including raw ewes and goat milk, and artisanal ewes and goat cheeses, were preliminarily screened for antimicrobial compound production against the indicator strains using an agar spot method \[[@B23]\]. Overnight cultures of lactococci were spotted (10 *μ*L) onto the surface of MRS agar (1.2% (w/v) agar---0.2% (w/v) glucose) plates, which were then incubated anaerobically for 24 h at 37°C. The indicator strains were inoculated into 7 mL of soft agar medium (MRS or nutrient broth containing 0.7% w/v agar) to a final concentration of approximately 10^7^ CFU/mL. The soft media were poured on the plates which were incubated for 24 h at the optimal growth temperature and atmosphere for the indicator strains. Inhibition was scored positive in the presence of a detectable clear zone around the colony of the producer strain.

2.3. Antimicrobial Activity Assay {#sec2.3}
---------------------------------

The lactococcal strains exhibiting an inhibitory activity against at least three indicator strains, among which are *L. monocytogenes* ATCC 7644 and the bacteriocin-sensitive strain *L. sakei* subsp. *sakei* DSMZ 20017, were further tested for their antimicrobial activity against *L. monocytogenes* ATCC 7644 using the well-diffusion method as described by Shillinger and Lücke \[[@B23]\] with some modifications. Briefly, 1% (v/v) aliquot of overnight culture of the indicator strain was inoculated into 20 mL of appropriate soft agar medium and poured into Petri dishes. After cooling, wells (6 mm diameter) were cut into the agar and filled with 100 *μ*L aliquots of cell-free supernatant of the potential producer strain collected by centrifugation (10000 ×g, 15 min). In order to eliminate the inhibitory effect of lactic acid and/or H~2~O~2~, the supernatants were adjusted to pH 6.5 with 5 M NaOH, treated with catalase (1 mg/mL, Sigma, Milan, Italy), and then filtered through a 0.45 *μ*m pore-size cellulose acetate filter (Millipore, Bedford MA, USA) prior to use. The plates were refrigerated for 4 h to allow the radial diffusion of the compounds contained in the supernatant prior to incubation for 24 h at 37°C. The antimicrobial activity was expressed as the diameter of the inhibition zones around the wells. The nisin-positive *L. lactis* subsp. *lactis* ATCC 11454 was used as positive control. Sterile M17 broth was used as negative control.

Sensitivity to proteolytic enzymes of the cell-free supernatants of bacteriocin producer strains was tested by treatment with pronase E, proteinase K, *α*-chymotrypsin, trypsin, and papain (Sigma). All enzymes (10 mg/mL in sterile distilled water) were filter sterilized and added to supernatants at a final concentration of 1 mg/mL in phosphate buffer (pH 6.5). Following incubation at 37°C for 2 h, enzymes were denatured by heating at 100°C for 5 min. Untreated samples were used as controls. The residual activity of enzyme-treated samples against *L. monocytogenes*ATCC 7644 was determined by the well-diffusion method.

2.4. Antilisterial Activity: Coculture Tests in Skimmed Milk {#sec2.4}
------------------------------------------------------------

Bacteriocinogenic *L. lactis* subsp. *lactis*strains were separately cocultured with *L. monocytogenes* ATCC 7644 in 100 mL of 10% reconstituted skimmed milk (RSM; Oxoid, Basingstoke, UK) at 30°C for 24 h. Bacteriocinogenic strains were inoculated at about 5 × 10^6^ CFU/mL, and *L. monocytogenes* had a final count of 10^6^ CFU/mL. In each experiment, negative control without bacteria, control inoculated with *L. monocytogenes* alone, and control inoculated with bacteriocinogenic strain alone were included. After 0, 5, 10, and 24 h, samples were taken, serially diluted in sterile saline solution, and plated onto M17 agar plates for the enumeration of *L. lactis* and on PALCAM (Microbiol) agar plates for the enumeration of *L. monocytogenes*. Values of pH were also monitored by using a HI8520 pH meter (P.B.I., Milan, Italy).

2.5. Safety Assessment of Strains {#sec2.5}
---------------------------------

The method of Bover-Cid and Holzapfel \[[@B24]\] was used to screen *Lactococcus* strains for the production of biogenic amines. Briefly, the test strains were subcultured twice at 24 h intervals in M17 broth containing 1% of each precursor amino acid: tyrosine disodium salt, ~L-~histidine monohydrochloride, ~L-~ornithine monohydrochloride and lysine monohydrochloride (Sigma), and 0.005% pyridoxal-5-phosphate (Sigma) as a codecarboxylase factor. All strains were then streaked in duplicate on decarboxylase medium plates each containing only one of the above-mentioned amino acids and bromocresol purple as pH indicator and incubated for 4 days in anaerobic conditions at 37°C. Decarboxylase medium without amino acids was used as control. A colour change from brown to purple in the medium indicated an increase in pH and was considered a positive result.

Haemolytic activity was determined by streaking the strains on Columbia Blood (Microbiol) agar plates supplemented with 5% defibrinated sheep blood after 48 h of incubation at 37°C. The haemolytic reaction was recorded by observation of a clear zone of hydrolysis around the colonies (*β*-haemolysis), a partial hydrolysis, and greenish zone (*α*-haemolysis) or no reaction.

Antibiotic susceptibility testing was carried out by disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines \[[@B25]\], but Mueller-Hinton agar was replaced by M17 agar. The following antibiotics (Oxoid or BBL) were tested: ampicillin (AM; 10 *μ*g), vancomycin (VA; 30 *μ*g) (inhibitors of cell wall synthesis), streptomycin (S; 10 *μ*g), tetracycline (TE; 30 *μ*g), gentamicin (GM; 10 *μ*g), kanamycin (K; 30 *μ*g), erythromycin (E; 15 *μ*g), chloramphenicol (C; 30 *μ*g), clindamycin (CM; 2 *μ*g) (inhibitors of protein synthesis), ciprofloxacin (CIP; 5 *μ*g), and trimethoprim/sulphamethoxazole (SXT; 25 *μ*g) (inhibitors of nucleic acids). A suspension from fresh overnight cultures with a density of McFarland 0.5 in buffered saline was plated on M17 agar plates; then, antibiotic discs were dispensed onto the plates. After incubation at 37°C for 24 h in anaerobiosis, the diameters of the bacterial-free zone were measured, and results were expressed in terms of resistance according to the interpretative criteria issued by the CLSI \[[@B26]\].

3. Results and Discussion {#sec3}
=========================

The antagonistic effect of LAB dairy strains on pathogenic microorganisms could be used for expanding the range of healthful dairy foods. LAB, originally isolated from raw milk or artisanal dairy products, are probably the best candidate for improving the microbiological safety of these foods, because they are well adapted to the conditions of the substrate.

In this study a total of 117 *Lactococcus lactis* subsp. *lactis* strains, isolated from artisanal Sardinian dairy products, were preliminarily screened for antimicrobial compound production against six indicator strains, including well-recognized foodborne pathogens, by means of an agar spot method ([Figure 1](#fig1){ref-type="fig"}). Twenty-eight strains were found to produce an inhibition zone against at least three indicators, among which are *Listeria monocytogenes* ATCC 7644 and the bacteriocin-sensitive strain *Lactobacillus sakei* subsp. *sakei* DSMZ 20017, and were selected for further investigation. Subsequently, the cell-free supernatants from these strains were treated with catalase, neutralized, sterilized by filtration, and tested by well-diffusion assay against *L. monocytogenes* ATCC 7644. Six *L. lactis* subsp. *lactis*, representing 5% of the strain tested, were found to retain antimicrobial activity, showing around the well a measurable clear zone with mean values ranging from 2.3 to 3.7 mm ([Table 2](#tab2){ref-type="table"}, control). The substances produced by these strains were neither hydrogen peroxide nor organic acid since the inhibitory activity was not affected by catalase and was maintained in neutralized supernatants.

Several studies have demonstrated the antagonistic activity of autochthonous cultures isolated from dairy products against *L. monocytogenes* \[[@B27]--[@B29]\]. The occurrence of bacteriocin-producing *Lactococcus* strains found in our study is lower than previously reported \[[@B27], [@B28]\]. On the other hand, the frequency of isolation of bacteriocin-producing strains is variable and could be attributed to differences such as the origin of the strains, the isolation media and technique used to detect antibacterial activity, and the diversity of indicator microorganisms used for initial screening.

The cell-free supernatants from the six strains producing antimicrobial compounds were assayed for sensitivity to proteolytic enzymes. The antimicrobial substances from all strains were completely inactivated by treatment with pronase E and proteinase K and partially eliminated with *α*-chymotrypsin. However, no loss of activity was observed when the supernatants were treated with trypsin and papain ([Table 2](#tab2){ref-type="table"}). The sensitivity to proteolytic enzymes of the strains was similar to that observed in the nisin A-producer *L. lactis* subsp. *lactis* ATCC 11454 used as experimental control, thus suggesting that the inhibitory activity is related to heat-stable proteinaceous compounds and may be due to nisin-like molecules which many strains of *L. lactis* are known to produce \[[@B29], [@B30]\]. Further studies including purification, molecular characterization, and sequence determination of nisin genes are being currently carried out in our laboratory to confirm these findings.

The effects of the bacteriocin-producing strains on the growth of *L. monocytogenes* ATCC 7644 in skimmed milk are presented in [Figure 2](#fig2){ref-type="fig"}. Growth of *L. monocytogenes* increased from 10^6^ CFU/mL to 10^8^ CFU/mL within 10 h in control samples, reaching about 10^9^ CFU/mL after 24 h of incubation. When *L. monocytogenes* was grown in co-culture with the bacteriocin-producing strains, different trends in the growth were obtained. As can be seen, the bacteriocin-producing strains reduced *L. monocytogenes* population within 10 h, although differences in the degree of inhibition were observed among the strains. The *L. monocytogenes* counts were reduced by approximately 4 log units compared to the positive control and by 2 log unit compared to the initial inoculum. The inhibition did not seem to be correlated with the reduction in pH during the first 10 hours of fermentation, confirming that the antimicrobial activity of the strains is not due to the production of organic acid. Our results suggest that these Bac+ strains could be potentially applied in cheese-manufacturing to control the growth of *L. monocytogenes*. In a previous study, a Bac+ *L. lactis* strain used in the manufacture of Jben cheese was able to reduce the growth of *L. monocytogenes* by 2.7 log units after 30 h of processing when an initial inoculum of 10^7^ CFU/mL was used \[[@B31]\].

In order for a strain to be used as bioprotective culture, it should be carefully evaluated for the presence of virulence factors, to determine what potential risks might be involved in its use. The formation of biogenic amines is of concern in terms of food safety and quality. Biogenic amines are produced by LAB during the process of fermentation of foods and beverages by amino acid decarboxylation. Bover-Cid and Holzapfel \[[@B24]\] suggested that the capability to produce biogenic amines in a synthetic medium might be strain dependent rather than being related to specific species. In our screening, none of the strains tested was found to decarboxylate lysine, histidine, ornithine, or tyrosine (data not shown), in agreement with other findings \[[@B32], [@B33]\].

Haemolytic activity is a trait associated with virulence in some food-associated microorganisms, such as enterococci \[[@B34], [@B35]\], but it has not been frequently reported for lactococci of dairy origin \[[@B36]\]. In our study no strain showed haemolytic activity on sheep blood (data not shown).

The antimicrobial resistance of *Lactococcus* strains is reported in [Table 3](#tab3){ref-type="table"}. Within the group of antimicrobial agents that inhibit the cell wall synthesis, all strains were susceptible to ampicillin and vancomycin. All strains were also susceptible to tetracycline, erythromycin, chloramphenicol, and clindamycin. Regarding the aminoglycosides, all strains were resistant to streptomycin, the majority to kanamycin and two to gentamycin. As for the antibiotics that inhibit the nucleic acids synthesis, all strains were resistant to trimethoprim/sulphametoxazole and none to ciprofloxacin. When multiple resistance is taken into account, two strains were resistant to two antibiotics, two to three, and two to four. Because of their long-time use in various food and feed products, LAB have been given the GRAS status \[[@B37], [@B38]\]; however, several studies have recently documented the presence and expression of antibiotic resistance genes in food-associated LAB including probiotics \[[@B39], [@B40]\], even though this trait is not commonly found in dairy LAB species \[[@B41]\]. Recently, the European Food Safety Authority (EFSA) has introduced the Qualified Presumption of Safety (QPS) concept, which is similar to the GRAS system in the United States and would allow microorganisms for which there are no special safety concerns to enter the market without extensive testing requirements \[[@B42]\]. The presence of acquired antibiotic resistance is considered by EFSA an important safety criterion for determining a strain\'s QPS status \[[@B43]\]. In this study, all strains analysed were generally resistant to aminoglycosides and trimethoprim/sulphametoxazole and sensitive to other clinically important antibiotics such as ampicillin, tetracycline, and vancomycin, in agreement with other findings \[[@B36], [@B44], [@B45]\], but in contrast with some reports where a high frequency of tetracycline resistance in *L. lactis* of probiotic and dairy origin was observed \[[@B46], [@B47]\], or a high percentage of *L. lactis* strains resistant to ciprofloxacin found \[[@B48]\]. As previously reported \[[@B48]\], different results may be explained by the lack of standardization in phenotypic antibiotic resistance testing in LAB food isolates, including differences in methods and media used.

Resistance to some antibiotics such as aminoglycosides has been reported to be intrinsic for lactococci \[[@B44], [@B48], [@B49]\]; but particular attention should be paid to the presence of transferable resistance, since strains of *L. lactis* have been reported to harbor different plasmid-encoded resistance determinants \[[@B40], [@B46], [@B50]\].

4. Conclusions {#sec4}
==============

The *in situ* production of bacteriocins by lactococcal strains in dairy foods provides a very attractive alternative to the use of purified bacteriocin, since many of them also generate specific aromas and flavors, but several issues including safety and adequate technological properties of the selected strains need to be addressed.

As the *L. lactis* strains tested in our study originated from artisanal goat and sheep dairy products and exhibited a strong inhibitory activity against *L. monocytogenes*, they may be useful in controlling the growth of this pathogen in dairy fermentation. The low level of antibiotic resistance observed in our strains could be of interest for a possible technological application since it has been demonstrated that *L. lactis*isolates displaying properties of technological interest generally exhibited a low-resistance phenotype (less than two antibiotics) \[[@B44]\].

Application of these bacteriocin-producing strains in food system studies is necessary to determine their effectiveness. The characterization of the bacteriocins and the technological properties of the strains are currently being investigated.

![Preliminary screening for antibacterial activity of *Lactococcus lactis*subsp*. lactis*strains isolated from artisanal dairy products.](JBB2012-376428.001){#fig1}

![Growth of *Listeria monocytogenes*in co-culture with *Lactococcus lactis* subsp. *lacti*s bacteriocin-producing strains. Microbial counts were calculated as the number of colony-forming units (CFU) per mL and reported as log~10~ CFU/mL. Data are expressed as mean ± standard errors from two independent experiments each with two replicates.](JBB2012-376428.002){#fig2}

###### 

Bacteriocinogenic strains of *Lactococcus lactis* subsp. *lactis* and indicator bacteria used in this study.

  Species                                Strain    Origin
  -------------------------------------- --------- ---------------
  Bacteriocinogenic strains                        
  *Lactococcus lactis* subsp. *lactis*   9FS16     Ewes cheese
  *Lactococcus lactis* subsp. *lactis*   16FS16    Ewes cheese
  *Lactococcus lactis* subsp. *lactis*   9/20234   Raw ewes milk
  *Lactococcus lactis* subsp. *lactis*   6LS5      Raw ewes milk
  *Lactococcus lactis* subsp. *lactis*   3LC39     Raw goat milk
  *Lactococcus lactis* subsp. *lactis*   1LC18     Raw goat milk
                                                   
  Indicator strains                                
  *Listeria monocytogenes*               7644      ATCC
  *Escherichia coli*                     35150     ATCC
  *Enterococcus faecalis*                29212     ATCC
  *Staphylococcus aureus*                25923     ATCC
  *Lactobacillus plantarum*              20174     DSMZ
  *Lactobacillus sakei* subsp. *sakei*   20017     DSMZ

###### 

Enzyme sensitivity of the antibacterial compounds produced by the six *Lactococcus lactis* subsp. *lactis*determined by well-diffusion assay. Results are expressed as mean ± standard deviation of three independent experiments.

  Producer strains            Control   Residual activity against *L. monocytogenes* ATCC 7644 after enzymes treatment\*                   
  --------------------------- --------- ---------------------------------------------------------------------------------- --- ----- ----- -----
  9FS16                       3.7       0                                                                                  0   2     3.7   3.7
  16FS16                      3.7       0                                                                                  0   2     3.7   3.7
  9/20234                     2.3       0                                                                                  0   0.8   2.3   2.3
  6LS5                        3.7       0                                                                                  0   0.5   3.7   3.7
  3LC39                       3.0       0                                                                                  0   0.5   3.0   3.0
  1LC18                       2.5       0                                                                                  0   0.7   2.5   2.5
  *Lc. lactis*ATCC 11454^§^   2.7       0                                                                                  0   1.7   2.7   2.7

\*Inhibition zone in mm.

^§^Nisin A-producer.

###### 

Antibiotic resistance of the six bacteriocin-producing *Lactococcus lactis* subsp. *lactis* strains isolated from artisanal dairy products.

  Antibiotic tested           9FS16   16FS16   9/20234   6LS5   3LC39   1LC18
  --------------------------- ------- -------- --------- ------ ------- -------
  Ampicillin (10 *μ*g)        S       S        S         S      S       S
  Vancomycin (30 *μ*g)        S       S        S         S      S       S
  Streptomycin (10 *μ*g)      R       R        R         R      R       R
  Tetracycline (30 *μ*g)      S       S        S         S      S       S
  Gentamicin (10 *μ*g)        R       R        S         S      S       S
  Kanamycin (30 *μ*g)         R       R        R         R      S       S
  Erythromycin (15 *μ*g)      S       S        S         S      S       S
  Chloramphenicol (30 *μ*g)   S       S        S         S      S       S
  Clindamycin (2 *μ*g)        S       S        S         S      S       S
  Ciprofloxacin (5 *μ*g)      S       S        S         S      S       S
  Cotrimoxazole (25 *μ*g)     R       R        R         R      R       R

[^1]: Academic Editor: Tai Hoon Kim
